| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |